0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemoglobinopathy Testing Services Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-7H6167
Home | Market Reports | Health| Pharmacy
Global Hemoglobinopathy Testing Services Market Insights Forecast to 2028
BUY CHAPTERS

Global Hemoglobinopathy Testing Services Market Research Report 2025

Code: QYRE-Auto-7H6167
Report
September 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemoglobinopathy Testing Services Market Size

The global market for Hemoglobinopathy Testing Services was valued at US$ 988 million in the year 2024 and is projected to reach a revised size of US$ 1832 million by 2031, growing at a CAGR of 9.4% during the forecast period.

Hemoglobinopathy Testing Services Market

Hemoglobinopathy Testing Services Market

Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Hemoglobin is present in the red blood cells that transports oxygen from the lung to the body.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hemoglobinopathy Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoglobinopathy Testing Services.
The Hemoglobinopathy Testing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemoglobinopathy Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemoglobinopathy Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Hemoglobinopathy Testing Services Market Report

Report Metric Details
Report Name Hemoglobinopathy Testing Services Market
Accounted market size in year US$ 988 million
Forecasted market size in 2031 US$ 1832 million
CAGR 9.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, AstraZeneca, Bluebird Bio, Bristol-Myers Squibb, Emmaus Medical, Acceleron Pharma, HemaQuest Pharmaceuticals, Eli Lilly and Company, Celgene Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hemoglobinopathy Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Hemoglobinopathy Testing Services Market growing?

Ans: The Hemoglobinopathy Testing Services Market witnessing a CAGR of 9.4% during the forecast period 2025-2031.

What is the Hemoglobinopathy Testing Services Market size in 2031?

Ans: The Hemoglobinopathy Testing Services Market size in 2031 will be US$ 1832 million.

Who are the main players in the Hemoglobinopathy Testing Services Market report?

Ans: The main players in the Hemoglobinopathy Testing Services Market are Novartis, AstraZeneca, Bluebird Bio, Bristol-Myers Squibb, Emmaus Medical, Acceleron Pharma, HemaQuest Pharmaceuticals, Eli Lilly and Company, Celgene Corporation

What are the Application segmentation covered in the Hemoglobinopathy Testing Services Market report?

Ans: The Applications covered in the Hemoglobinopathy Testing Services Market report are Sickle Cell Diseases, Thalassemia, Other

What are the Type segmentation covered in the Hemoglobinopathy Testing Services Market report?

Ans: The Types covered in the Hemoglobinopathy Testing Services Market report are Hydroxyurea, Glutamine, Zynteglo, Luspatercept, Others

Recommended Reports

Hemoglobin Testing

Blood Testing Devices

Hematology Analytics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hydroxyurea
1.2.3 Glutamine
1.2.4 Zynteglo
1.2.5 Luspatercept
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hemoglobinopathy Testing Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Sickle Cell Diseases
1.3.3 Thalassemia
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemoglobinopathy Testing Services Market Perspective (2020-2031)
2.2 Global Hemoglobinopathy Testing Services Growth Trends by Region
2.2.1 Global Hemoglobinopathy Testing Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hemoglobinopathy Testing Services Historic Market Size by Region (2020-2025)
2.2.3 Hemoglobinopathy Testing Services Forecasted Market Size by Region (2026-2031)
2.3 Hemoglobinopathy Testing Services Market Dynamics
2.3.1 Hemoglobinopathy Testing Services Industry Trends
2.3.2 Hemoglobinopathy Testing Services Market Drivers
2.3.3 Hemoglobinopathy Testing Services Market Challenges
2.3.4 Hemoglobinopathy Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemoglobinopathy Testing Services Players by Revenue
3.1.1 Global Top Hemoglobinopathy Testing Services Players by Revenue (2020-2025)
3.1.2 Global Hemoglobinopathy Testing Services Revenue Market Share by Players (2020-2025)
3.2 Global Hemoglobinopathy Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hemoglobinopathy Testing Services Revenue
3.4 Global Hemoglobinopathy Testing Services Market Concentration Ratio
3.4.1 Global Hemoglobinopathy Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Testing Services Revenue in 2024
3.5 Global Key Players of Hemoglobinopathy Testing Services Head office and Area Served
3.6 Global Key Players of Hemoglobinopathy Testing Services, Product and Application
3.7 Global Key Players of Hemoglobinopathy Testing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemoglobinopathy Testing Services Breakdown Data by Type
4.1 Global Hemoglobinopathy Testing Services Historic Market Size by Type (2020-2025)
4.2 Global Hemoglobinopathy Testing Services Forecasted Market Size by Type (2026-2031)
5 Hemoglobinopathy Testing Services Breakdown Data by Application
5.1 Global Hemoglobinopathy Testing Services Historic Market Size by Application (2020-2025)
5.2 Global Hemoglobinopathy Testing Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hemoglobinopathy Testing Services Market Size (2020-2031)
6.2 North America Hemoglobinopathy Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hemoglobinopathy Testing Services Market Size by Country (2020-2025)
6.4 North America Hemoglobinopathy Testing Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemoglobinopathy Testing Services Market Size (2020-2031)
7.2 Europe Hemoglobinopathy Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hemoglobinopathy Testing Services Market Size by Country (2020-2025)
7.4 Europe Hemoglobinopathy Testing Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemoglobinopathy Testing Services Market Size (2020-2031)
8.2 Asia-Pacific Hemoglobinopathy Testing Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemoglobinopathy Testing Services Market Size (2020-2031)
9.2 Latin America Hemoglobinopathy Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hemoglobinopathy Testing Services Market Size by Country (2020-2025)
9.4 Latin America Hemoglobinopathy Testing Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemoglobinopathy Testing Services Market Size (2020-2031)
10.2 Middle East & Africa Hemoglobinopathy Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Hemoglobinopathy Testing Services Introduction
11.1.4 Novartis Revenue in Hemoglobinopathy Testing Services Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Hemoglobinopathy Testing Services Introduction
11.2.4 AstraZeneca Revenue in Hemoglobinopathy Testing Services Business (2020-2025)
11.2.5 AstraZeneca Recent Development
11.3 Bluebird Bio
11.3.1 Bluebird Bio Company Details
11.3.2 Bluebird Bio Business Overview
11.3.3 Bluebird Bio Hemoglobinopathy Testing Services Introduction
11.3.4 Bluebird Bio Revenue in Hemoglobinopathy Testing Services Business (2020-2025)
11.3.5 Bluebird Bio Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Hemoglobinopathy Testing Services Introduction
11.4.4 Bristol-Myers Squibb Revenue in Hemoglobinopathy Testing Services Business (2020-2025)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Emmaus Medical
11.5.1 Emmaus Medical Company Details
11.5.2 Emmaus Medical Business Overview
11.5.3 Emmaus Medical Hemoglobinopathy Testing Services Introduction
11.5.4 Emmaus Medical Revenue in Hemoglobinopathy Testing Services Business (2020-2025)
11.5.5 Emmaus Medical Recent Development
11.6 Acceleron Pharma
11.6.1 Acceleron Pharma Company Details
11.6.2 Acceleron Pharma Business Overview
11.6.3 Acceleron Pharma Hemoglobinopathy Testing Services Introduction
11.6.4 Acceleron Pharma Revenue in Hemoglobinopathy Testing Services Business (2020-2025)
11.6.5 Acceleron Pharma Recent Development
11.7 HemaQuest Pharmaceuticals
11.7.1 HemaQuest Pharmaceuticals Company Details
11.7.2 HemaQuest Pharmaceuticals Business Overview
11.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Introduction
11.7.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Testing Services Business (2020-2025)
11.7.5 HemaQuest Pharmaceuticals Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Hemoglobinopathy Testing Services Introduction
11.8.4 Eli Lilly and Company Revenue in Hemoglobinopathy Testing Services Business (2020-2025)
11.8.5 Eli Lilly and Company Recent Development
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Details
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Hemoglobinopathy Testing Services Introduction
11.9.4 Celgene Corporation Revenue in Hemoglobinopathy Testing Services Business (2020-2025)
11.9.5 Celgene Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Hydroxyurea
 Table 3. Key Players of Glutamine
 Table 4. Key Players of Zynteglo
 Table 5. Key Players of Luspatercept
 Table 6. Key Players of Others
 Table 7. Global Hemoglobinopathy Testing Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Hemoglobinopathy Testing Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Hemoglobinopathy Testing Services Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Hemoglobinopathy Testing Services Market Share by Region (2020-2025)
 Table 11. Global Hemoglobinopathy Testing Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Hemoglobinopathy Testing Services Market Share by Region (2026-2031)
 Table 13. Hemoglobinopathy Testing Services Market Trends
 Table 14. Hemoglobinopathy Testing Services Market Drivers
 Table 15. Hemoglobinopathy Testing Services Market Challenges
 Table 16. Hemoglobinopathy Testing Services Market Restraints
 Table 17. Global Hemoglobinopathy Testing Services Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Hemoglobinopathy Testing Services Market Share by Players (2020-2025)
 Table 19. Global Top Hemoglobinopathy Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Testing Services as of 2024)
 Table 20. Ranking of Global Top Hemoglobinopathy Testing Services Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Hemoglobinopathy Testing Services Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Hemoglobinopathy Testing Services, Headquarters and Area Served
 Table 23. Global Key Players of Hemoglobinopathy Testing Services, Product and Application
 Table 24. Global Key Players of Hemoglobinopathy Testing Services, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Hemoglobinopathy Testing Services Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2020-2025)
 Table 28. Global Hemoglobinopathy Testing Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2026-2031)
 Table 30. Global Hemoglobinopathy Testing Services Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2020-2025)
 Table 32. Global Hemoglobinopathy Testing Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2026-2031)
 Table 34. North America Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Hemoglobinopathy Testing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Hemoglobinopathy Testing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Hemoglobinopathy Testing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Hemoglobinopathy Testing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Hemoglobinopathy Testing Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Hemoglobinopathy Testing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Hemoglobinopathy Testing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Novartis Company Details
 Table 50. Novartis Business Overview
 Table 51. Novartis Hemoglobinopathy Testing Services Product
 Table 52. Novartis Revenue in Hemoglobinopathy Testing Services Business (2020-2025) & (US$ Million)
 Table 53. Novartis Recent Development
 Table 54. AstraZeneca Company Details
 Table 55. AstraZeneca Business Overview
 Table 56. AstraZeneca Hemoglobinopathy Testing Services Product
 Table 57. AstraZeneca Revenue in Hemoglobinopathy Testing Services Business (2020-2025) & (US$ Million)
 Table 58. AstraZeneca Recent Development
 Table 59. Bluebird Bio Company Details
 Table 60. Bluebird Bio Business Overview
 Table 61. Bluebird Bio Hemoglobinopathy Testing Services Product
 Table 62. Bluebird Bio Revenue in Hemoglobinopathy Testing Services Business (2020-2025) & (US$ Million)
 Table 63. Bluebird Bio Recent Development
 Table 64. Bristol-Myers Squibb Company Details
 Table 65. Bristol-Myers Squibb Business Overview
 Table 66. Bristol-Myers Squibb Hemoglobinopathy Testing Services Product
 Table 67. Bristol-Myers Squibb Revenue in Hemoglobinopathy Testing Services Business (2020-2025) & (US$ Million)
 Table 68. Bristol-Myers Squibb Recent Development
 Table 69. Emmaus Medical Company Details
 Table 70. Emmaus Medical Business Overview
 Table 71. Emmaus Medical Hemoglobinopathy Testing Services Product
 Table 72. Emmaus Medical Revenue in Hemoglobinopathy Testing Services Business (2020-2025) & (US$ Million)
 Table 73. Emmaus Medical Recent Development
 Table 74. Acceleron Pharma Company Details
 Table 75. Acceleron Pharma Business Overview
 Table 76. Acceleron Pharma Hemoglobinopathy Testing Services Product
 Table 77. Acceleron Pharma Revenue in Hemoglobinopathy Testing Services Business (2020-2025) & (US$ Million)
 Table 78. Acceleron Pharma Recent Development
 Table 79. HemaQuest Pharmaceuticals Company Details
 Table 80. HemaQuest Pharmaceuticals Business Overview
 Table 81. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Product
 Table 82. HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Testing Services Business (2020-2025) & (US$ Million)
 Table 83. HemaQuest Pharmaceuticals Recent Development
 Table 84. Eli Lilly and Company Company Details
 Table 85. Eli Lilly and Company Business Overview
 Table 86. Eli Lilly and Company Hemoglobinopathy Testing Services Product
 Table 87. Eli Lilly and Company Revenue in Hemoglobinopathy Testing Services Business (2020-2025) & (US$ Million)
 Table 88. Eli Lilly and Company Recent Development
 Table 89. Celgene Corporation Company Details
 Table 90. Celgene Corporation Business Overview
 Table 91. Celgene Corporation Hemoglobinopathy Testing Services Product
 Table 92. Celgene Corporation Revenue in Hemoglobinopathy Testing Services Business (2020-2025) & (US$ Million)
 Table 93. Celgene Corporation Recent Development
 Table 94. Research Programs/Design for This Report
 Table 95. Key Data Information from Secondary Sources
 Table 96. Key Data Information from Primary Sources
 Table 97. Authors List of This Report


List of Figures
 Figure 1. Hemoglobinopathy Testing Services Picture
 Figure 2. Global Hemoglobinopathy Testing Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hemoglobinopathy Testing Services Market Share by Type: 2024 VS 2031
 Figure 4. Hydroxyurea Features
 Figure 5. Glutamine Features
 Figure 6. Zynteglo Features
 Figure 7. Luspatercept Features
 Figure 8. Others Features
 Figure 9. Global Hemoglobinopathy Testing Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Hemoglobinopathy Testing Services Market Share by Application: 2024 VS 2031
 Figure 11. Sickle Cell Diseases Case Studies
 Figure 12. Thalassemia Case Studies
 Figure 13. Other Case Studies
 Figure 14. Hemoglobinopathy Testing Services Report Years Considered
 Figure 15. Global Hemoglobinopathy Testing Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Hemoglobinopathy Testing Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Hemoglobinopathy Testing Services Market Share by Region: 2024 VS 2031
 Figure 18. Global Hemoglobinopathy Testing Services Market Share by Players in 2024
 Figure 19. Global Top Hemoglobinopathy Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Testing Services as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Hemoglobinopathy Testing Services Revenue in 2024
 Figure 21. North America Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Hemoglobinopathy Testing Services Market Share by Country (2020-2031)
 Figure 23. United States Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Hemoglobinopathy Testing Services Market Share by Country (2020-2031)
 Figure 27. Germany Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Hemoglobinopathy Testing Services Market Share by Region (2020-2031)
 Figure 35. China Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Hemoglobinopathy Testing Services Market Share by Country (2020-2031)
 Figure 43. Mexico Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Hemoglobinopathy Testing Services Market Share by Country (2020-2031)
 Figure 47. Turkey Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Hemoglobinopathy Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Novartis Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2020-2025)
 Figure 51. AstraZeneca Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2020-2025)
 Figure 52. Bluebird Bio Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2020-2025)
 Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2020-2025)
 Figure 54. Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2020-2025)
 Figure 55. Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2020-2025)
 Figure 56. HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2020-2025)
 Figure 57. Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2020-2025)
 Figure 58. Celgene Corporation Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart